CNNA OTC
Cann American Corp.
1W: -14.0%
1M: -9.3%
3M: -18.3%
YTD: +145.0%
1Y: +96.0%
3Y: +276.9%
5Y: -69.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±27.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.6M
52W Range0.0001-0.0098
Volume301,711
Avg Volume635,668
Beta-0.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJason R. Tucker
Employees1
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2011-02-14
Websitecnnacorp.com
121 South Orange Avenue
Orlando, FL 32801
US
Orlando, FL 32801
US
770-866-6250
About Cann American Corp.
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| DAHLERUP HENRIK | 0 | — | 2011-01-25 | |
| SCHIORRING KRISTIAN | 0 | — | 2011-01-25 | |
| WONG GARRY E | S-Sale | 12,856,667 | $0.00 | 2011-01-25 |
| WONG GARRY E | S-Sale | 75,643,333 | — | 2011-01-25 |
| WONG GARRY E | 0 | — | 2011-01-25 |